VRXANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as VRXAW
Veraxa Biotech AG - Post de-SPAC
Last filing: 20-F on Jun 16, 2026
$1.00−0.11 (-9.91%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$9.50 (−90.48%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –